The worldwide colposcopy market accounted for US$ 455Mn in 2021 and is expected to hit US$ 711 Mn by 2030, with a significant CAGR of 5.3% from 2022 to 2030.

A colposcopy is used to detect cancerous or potentially cancerous cells in the cervix, vagina, or vulva. The test determines whether the cells in the cervix are abnormal and whether it requires treatment to remove them. This minimally invasive procedure is carried out by a specialized tool called a colposcope. The medical professional inserts a speculum into the vagina to separate the walls so they can get a clear view of the cervix. If any abnormalities or an unusual area of cells is observed during the procedure, a tissue sample may be collected for laboratory testing. This procedure is called a biopsy. Generally, in colposcopy there are two types of biopsies – one take tissue from inside the cervix and the other takes tissue from outside the cervix.

Market Growth Drivers:

·         Rising burden of cervical cancer worldwide

·         Growing awareness among the population for early detection of disease

·         Rising technological advancement in colposcopes

·         Increasing elderly population

Market Restraints:

• Complications associated with the procedure
• Presence of alternative methods

Market Opportunities:

• Growing consciousness about the gynecological disease
• Growth opportunities in emerging countries

Covid-19 Impact on the Global Colposcopy Industry

The COVID-19 pandemic has put enormous strain on the healthcare system. This caused delays in the initiation and completion of cancer treatment. Many countries' lockdowns limited patient access to and attendance at outpatient medical visits, including preventive treatments like cervical cancer screening. Furthermore, the pandemic has had an impact on all aspects of cancer care and research, with cancer screening and care being designated as a low-priority service in various nations around the world. Thus, the overall industry was intensely impacted by the pandemic resulting in a significant downturn in revenue generation.

Market Dynamics

The increasing prevalence of cervical cancer is the primary factor driving the growth of the global colposcopy market. The infection with risky human papillomaviruses (HPV), an extremelyprevailingvirus spread through sexual intercourse, is linked with nearly all cervical cancer cases (99 percent). According to the World Health Organization (WHO), cervical cancer is the fourth most frequent cancer among women. Furthermore, the WHO data states that, cervical cancer was diagnosed in approximately 5,70,000 women worldwide in 2018, with around 3,11,000 women deaths due to the infection.

However, complications associated with these procedures and the presence of alternative methods could constrain the market from growing. In addition, according to evidence from WHO research, women may fear screening and have a high level of anxiety about colposcopy or therapy and may feel bothered by the necessity for a second visit for a procedure. On the other hand, the rising demand for colposcopes among emerging countries and increasing technological improvements in the colposcopy therapy are some of the aspects that are driving the market further with a bunch of potential growth opportunities.

Market Segmentation

The global colposcopymarket is segmented based onproduct type, portability, application, end-use, and geography.

Market by Product Type

·         Digital

·         Optical

Digital transformation is expected to drive the future of health. This applies to colposcopes as well. As a result, the digital colposcopes segment gathered a significant amount of share in 2021 due to their accuracy in the diagnosis of cervical cancer. In addition, medical testing and diagnosis have improved significantly as a result of advancements in digital camera technology and high-definition lenses. In addition to that, factors such as providing more comfort and space for the examiner, quick and accurate diagnosis of the cervix, and advancements in technology are supporting the digital segment growth.

Market by Portability

• Handheld
• Portable
• Stationary

In 2021, the portable segment held a noteworthy amount of share in the portability segment. The high growth in the segment is because of its portability, ease of handling, screening convenience, and higher adoption of portable colposcopes in hospitals and gynecological clinics. Besides, the handheld segment is likely to attain the highest growth rate throughout the forecast period 2022 – 2030. Factors such as compact nature, growing adoption in smaller clinics, and surging demand from home care and emergency care settings are propelling the segment growth.

Market by Application

• Oral
• Pelvic

The pelvic sub-segment captured the largest market share among applications in 2021 and is expected to maintain its dominance throughout the forecast period. The rising number of pelvic disorders and the increasing patient pool of gynecological diseases are the driving factors of the market. Pelvic inflammatory disease (PID) is an infection of the female reproductive organs. It usually happens when bacteria from the vagina spread to the uterus, ovaries, or fallopian tubes. However, the oral screening segment is anticipated to register a substantial growth rate in the coming years.

Market by End-Use

• Hospital
• Ambulatory Surgical Centers
• Gynecology Clinics
• Diagnostic Centers
• Specialty Clinics
• Research and Academics

In terms of end-use, the hospital sub-segment is expected to capture a sizable market share in the coming years. The market for hospitals is growing as they are fully equipped with the essential equipment used for the inspectionof the cervix. Meanwhile, the diagnostic center's segment will be growing with the fastest CAGR throughout the projected years due to the increasing inclination of patients to opt for these centers as they offer quick diagnoses compared to other healthcare facilities.

Colposcopy Market Regional Overview